EPS growth outshines yearly share price gain, hinting at cautious market sentiment. Despite recent sell-off, long-term investors see 16% annual return over five years, suggesting sell-off may be an opportunity for those seeking long-term growth.
The insider stock selling at Halozyme Therapeutics could raise concerns among shareholders. However, the fact that insiders maintain a considerable amount of shares might suggest some level of alignment between management and smaller shareholders.
Gapping up $Rivian Automotive (RIVN.US)$+6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.) $Celsius Holdings (CELH.US)$+11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
奥洛兹美医疗股票讨论
⇒ $Larimar Therapeutics (LRMR.US)$ 🟢
‣ FDA removes partial clinical hold
‣ Nomlabofusp (CTI-1601) #FA
‣ Protein replacement therapy
‣ Interim data from OLE in Q4 '24 🔔
Clinical readouts 📢
⇒ $Citius Pharmaceuticals (CTXR.US)$ 🟢
‣ Positive Ph3 topline results
‣ Mino-Lok® #CLABSI #CRBSI
‣ Antibiotic lock solution
‣ Overall treatment success in 57.1% patients
Regulatory Update🎯
⇒ $奥洛兹美医疗 (HALO.US)$ $施贵宝 (BMY.US)$
‣ FDA Reassigned PDUFA data to 12/29/24
‣ Subcutane...
$Rivian Automotive (RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings (CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
2022前三季度营收增长40%达到4.8亿,但由于费用的大幅增长,营业利润反而下滑12%,净利润下滑57%到1.44亿。
目前市盈率18.4,市盈率TTM已经达到了34,看起来全年结果也不会太好,目前没有吸引力。
Gap Ups
1. $Topbuild (BLD.US)$ - up 2.7%
2. $Atlassian (TEAM.US)$ - up 2.4%
3. $Pool Corp (POOL.US)$ - up 2%
4. $索尼 (SONY.US)$ - up 1.9%
5. $托尔兄弟 (TOL.US)$ - up 1.8%
6. $查尔斯河实验室 (CRL.US)$ - up 1.4%
7. $Gaming & Leisure Properties (GLPI.US)$ - up 1.4%
8. $WPP PLC (WPP.US)$ - up 1.3%...
Gap Ups
1. $Axon Enterprise (AXON.US)$ - up 7.79%
2. $韩国电力 (KEP.US)$ - up 6.65%
3. $Meta Platforms (META.US)$ - up 3.00%
4. $XP Inc (XP.US)$ - up 2.50%
5. $盖尔道钢铁 (GGB.US)$ - up 1.49%
6. $Performance Food (PFGC.US)$ - up 1.47%
7. $克罗格 (KR.US)$ - up 1.30%
8. $奥洛兹美医疗 (HALO.US)$ - up 0.94...
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $奥洛兹美医疗 (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $美国血液技术 (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
暂无评论